Psychemedics's Cash & cash equivalent grew by 0.85 % in the Q4 2024 sequentially, while Current Liabilities decreased, this led to improvement in Psychemedics's Quick Ratio to 0.52, Quick Ratio remained below Psychemedics Corporation average.

Within Medical Laboratories industry 26 other companies have achieved higher Quick Ratio than Psychemedics in fourth quarter 2024. While Quick Ratio total ranking in the fourth quarter 2024 has deteriorated compared to the prior quarter from 2130 to 2400.

Explain Quick Ratio?
How much Cash & cash equivalents PMD�s has?
What are PMD�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PMD Quick Ratio	(Dec 31 2024) Q4	(Sep 30 2024) Q3	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4
Y / Y Current Liabilities Change	-25.95 %	-12.34 %	-18 %	-11.24 %	-21.79 %
Y / Y Cash & cash equivalent Change	-27.85 %	2.55 %	-41.35 %	-67.56 %	-58.65 %
Quick Ratio MRQ	0.52	0.37	0.38	0.34	0.54
PMD's Total Ranking	# 2400	# 2130	# 2367	# 1964	# 1735
Seq. Current Liabilities Change	-28.53 %	1.17 %	-10.4 %	14.29 %	-15.39 %
Seq. Cash & cash equivalent Change	0.85 %	-2.02 %	0.91 %	-27.65 %	43.36 %

Quick Ratio fourth quarter 2024 Company Ranking
Within:	No.
Medical Laboratories Industry	# 27
Healthcare Sector	# 750
Overall Market	# 2400

Quick Ratio Statistics
High	Average	Low
3.52	1.09	0.32
(Mar 31 2012)		(Sep 30 2023)

Financial Statements
Psychemedics's Current Liabilities	$ 3 Millions	Visit PMD's Balance sheet
Psychemedics's Cash & cash equivalent	$ 1 Millions	Visit PMD's Balance sheet
Source of PMD's Sales		Visit PMD's Sales by Geography

Cumulative Psychemedics's Quick Ratio

PMD's Quick Ratio for the trailling 12 Months

PMD Quick Ratio	(Dec 31 2024) 12 Months	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months
Y / Y Current Liabilities TTM Growth	-16.42 %	-15.89 %	-16.9 %	-11.45 %	-6.75 %
Y / Y Cash & cash equivalent TTM Growth	-44.12 %	-51.92 %	-58.83 %	-49.92 %	-16.21 %
Quick Ratio TTM	0.39	0.4	0.39	0.43	0.59
Total Ranking TTM	# 3728	# 3446	# 3444	# 2687	# 1391
Seq. Current Liabilities TTM Growth	-6.17 %	-3.35 %	-4.92 %	-3.07 %	-5.58 %
Seq. Cash & cash equivalent TTM Growth	-8.79 %	0.57 %	-14.04 %	-29.13 %	-21.52 %

Quick ratio ranking by company, industry and sector >> Back to PMD Financial Strength Comparisons >> Go to Compare PMD Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in PMD's Current Liabilities to $2.71 millions, cumulative Quick Ratio to 0.39 below the PMD average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 38 other companies have achieved higher Quick Ratio than Psychemedics. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2024 from 3446 to 3728.

Explain Quick Ratio?
How much Cash & cash equivalents PMD�s has?
What are PMD�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 39
Healthcare Sector	# 951
Within the Market	# 3728

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.66	0.87	0.34
(Sep 30 2019)		(Jun 30 2024)

Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Medical Laboratories Industry	Quick Ratio	Dec 31 2024 MRQ Cash & cash equivalent	Dec 31 2024 MRQ Current Liabilities
American Shared Hospital Services	1.08	$ 11.275 Millions	$ 10.405 Millions
Incyte Corporation	1.03	$ 1,687.829 Millions	$ 1,641.847 Millions
Fulgent Genetics Inc	0.76	$ 55.144 Millions	$ 72.899 Millions
Inotiv Inc	0.71	$ 38.043 Millions	$ 53.491 Millions
Advanced Biomed Inc.	0.70	$ 2.657 Millions	$ 3.784 Millions
Check Cap Ltd	0.57	$ 0.530 Millions	$ 0.935 Millions
Psychemedics Corporation	0.52	$ 1.417 Millions	$ 2.711 Millions
Labcorp Holdings Inc	0.46	$ 1,518.700 Millions	$ 3,330.200 Millions
Aclarion Inc	0.39	$ 0.454 Millions	$ 1.153 Millions
Bioaffinity Technologies Inc	0.36	$ 1.105 Millions	$ 3.105 Millions
Iqvia Holdings Inc	0.36	$ 1,843.000 Millions	$ 5,178.000 Millions
Ispecimen inc	0.33	$ 1.891 Millions	$ 5.771 Millions
Quest Diagnostics Inc	0.28	$ 549.000 Millions	$ 1,996.000 Millions
Koninklijke Philips Nv	0.27	$ 2,794.400 Millions	$ 10,180.800 Millions
Charles River Laboratories International inc	0.26	$ 194.606 Millions	$ 745.779 Millions
Fortrea Holdings Inc	0.20	$ 118.500 Millions	$ 582.800 Millions
Icon Plc	0.18	$ 542.285 Millions	$ 3,014.980 Millions
Nrc Health	0.12	$ 4.233 Millions	$ 35.858 Millions

Date modified: 2026-06-22T11:02:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.